Business Segments · Foreign exchange and other
MedSurg and Neurotechnology — Foreign exchange and other
Stryker MedSurg and Neurotechnology — Foreign exchange and other decreased by 204.1% to -$19M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 204.1%, from $18.25M to -$19M. Over 4 years (FY 2021 to FY 2025), MedSurg and Neurotechnology — Foreign exchange and other shows an upward trend with a 53.9% CAGR.
Analysis
StatementSegment
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ1 2020
Last reportedQ1 2026May 11, 2026
Rolls up toTranslation and other
How to read this metric
An increase in negative impact signals unfavorable currency headwinds, while a decrease or positive value indicates favorable currency tailwinds or neutral conditions.
Detailed definition
This metric quantifies the impact of currency fluctuations and miscellaneous non-operational factors on the MedSurg and...
Peer comparison
Comparable to 'foreign currency translation impact' or 'FX impact' disclosed by global medical technology companies.
Metric ID:
syk_segment_medsurg_and_neurotechnology_foreign_exchange_and_otherHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$3.25M | -$3.25M | -$3.25M | -$13.5M | -$13.5M | -$13.5M | -$13.5M | $8.5M | $8.5M | $8.5M | $8.5M | $21.5M | $21.5M | $21.5M | $21.5M | $18.25M | $18.25M | $18.25M | $18.25M | -$19M |
| QoQ Change | — | +0.0% | +0.0% | -315.4% | +0.0% | +0.0% | +0.0% | +163.0% | +0.0% | +0.0% | +0.0% | +152.9% | +0.0% | +0.0% | +0.0% | -15.1% | +0.0% | +0.0% | +0.0% | -204.1% |
| YoY Change | — | — | — | — | -315.4% | -315.4% | -315.4% | +163.0% | +163.0% | +163.0% | +163.0% | +152.9% | +152.9% | +152.9% | +152.9% | -15.1% | -15.1% | -15.1% | -15.1% | -204.1% |
Range-$19M – $21.5M
CAGR+45.0%
Avg YoY Growth+3.3%
Median YoY Growth+68.9%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Stryker's medsurg and neurotechnology — foreign exchange and other?
- Stryker (SYK) reported medsurg and neurotechnology — foreign exchange and other of -$19M in Q1 2026.
- How has Stryker's medsurg and neurotechnology — foreign exchange and other changed year-over-year?
- Stryker's medsurg and neurotechnology — foreign exchange and other decreased by 204.1% year-over-year, from $18.25M to -$19M.
- What is the long-term trend for Stryker's medsurg and neurotechnology — foreign exchange and other?
- Over 4 years (2021 to 2025), Stryker's medsurg and neurotechnology — foreign exchange and other has grown at a 53.9% compound annual growth rate (CAGR), from -$13M to $73M.
- What does medsurg and neurotechnology — foreign exchange and other mean?
- The financial impact of currency exchange rate fluctuations and minor miscellaneous items on segment performance.